$1.18 Billion is the total value of Eversept Partners, LP's 69 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 36.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | Buy | INVESCO QQQ TRput | $143,308,000 | +10.8% | 400,000 | +14.3% | 12.13% | +12.2% |
| Buy | GSK PLCsponsored adr | $118,151,148 | +13.9% | 3,259,342 | +13.1% | 10.00% | +15.2% | |
| NTRA | Buy | NATERA INC | $110,299,143 | -6.1% | 2,492,636 | +3.3% | 9.33% | -4.9% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $102,595,200 | +0.6% | 240,000 | +4.3% | 8.68% | +1.9% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $70,911,267 | +22.8% | 6,952,085 | -9.3% | 6.00% | +24.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $60,511,251 | +5.3% | 267,903 | +2.9% | 5.12% | +6.6% |
| INSP | Buy | INSPIRE MED SYS INC | $38,302,492 | +43.1% | 193,018 | +134.1% | 3.24% | +44.8% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $37,697,477 | -17.7% | 2,596,245 | +18.6% | 3.19% | -16.8% |
| HCA | Buy | HCA HEALTHCARE INC | $27,075,757 | +10.5% | 110,073 | +36.4% | 2.29% | +11.9% |
| TECH | Buy | BIO-TECHNE CORP | $26,267,464 | -6.1% | 385,889 | +12.6% | 2.22% | -4.9% |
| DHR | Buy | DANAHER CORPORATION | $25,748,810 | +3.7% | 103,784 | +0.4% | 2.18% | +5.0% |
| HQY | New | HEALTHEQUITY INC | $24,728,594 | – | 338,516 | +100.0% | 2.09% | – |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $23,810,737 | -51.3% | 205,815 | -56.7% | 2.02% | -50.7% |
| ILMN | Buy | ILLUMINA INC | $22,895,833 | -1.6% | 166,782 | +34.4% | 1.94% | -0.4% |
| CYH | Sell | COMMUNITY HEALTH SYS INC NEW | $20,723,655 | -35.3% | 7,146,088 | -1.8% | 1.75% | -34.5% |
| VERA | Sell | VERA THERAPEUTICS INCcl a | $20,270,084 | -27.5% | 1,478,489 | -15.1% | 1.72% | -26.6% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $17,552,049 | +5.1% | 2,479,103 | +4.5% | 1.48% | +6.4% |
| SWAV | Buy | SHOCKWAVE MED INC | $16,816,384 | +192.6% | 84,462 | +319.4% | 1.42% | +195.8% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $16,185,695 | -39.3% | 588,143 | -25.1% | 1.37% | -38.5% |
| CNC | Buy | CENTENE CORP DEL | $13,129,010 | +27.4% | 190,607 | +24.8% | 1.11% | +29.0% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $12,617,436 | +0.9% | 108,771 | +2.2% | 1.07% | +2.2% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $11,450,951 | +15.5% | 252,446 | +4.5% | 0.97% | +16.9% |
| AMRX | Sell | AMNEAL PHARMACEUTICALS INC | $11,161,849 | -31.6% | 2,644,988 | -49.8% | 0.94% | -30.8% |
| PCVX | Sell | VAXCYTE INC | $9,708,121 | -0.7% | 190,430 | -2.7% | 0.82% | +0.6% |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $9,628,230 | +1.4% | 255,323 | +2.0% | 0.82% | +2.6% |
| ANTM | Buy | ELEVANCE HEALTH INC | $9,446,001 | +818.4% | 21,694 | +837.1% | 0.80% | +829.1% |
| LQDA | Buy | LIQUIDIA CORPORATION | $8,847,178 | +21.8% | 1,395,454 | +50.8% | 0.75% | +23.4% |
| HUM | Buy | HUMANA INC | $8,816,229 | +65.0% | 18,121 | +51.9% | 0.75% | +66.9% |
| IBB | New | ISHARES TRput | $8,596,987 | – | 70,300 | +100.0% | 0.73% | – |
| TLT | New | ISHARES TRput | $8,310,253 | – | 93,700 | +100.0% | 0.70% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $7,757,325 | -37.9% | 8,431,875 | -19.7% | 0.66% | -37.2% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $6,799,762 | – | 443,270 | +100.0% | 0.58% | – |
| HYG | New | ISHARES TRput | $6,634,800 | – | 90,000 | +100.0% | 0.56% | – |
| WAT | Buy | WATERS CORP | $6,340,832 | +117.7% | 23,124 | +111.6% | 0.54% | +120.1% |
| Sell | NEWAMSTERDAM PHARMA COMPANYordinary shares | $6,110,717 | -25.8% | 660,618 | -4.6% | 0.52% | -24.9% | |
| XBI | Sell | SPDR SER TRput | $5,841,600 | -22.0% | 80,000 | -11.1% | 0.49% | -21.1% |
| New | 2SEVENTY BIO INC | $5,697,242 | – | 1,453,378 | +100.0% | 0.48% | – | |
| MCRB | Sell | SERES THERAPEUTICS INC | $5,599,083 | -62.0% | 2,352,556 | -23.5% | 0.47% | -61.5% |
| TSHA | New | TAYSHA GENE THERAPIES INC | $5,390,246 | – | 1,705,774 | +100.0% | 0.46% | – |
| ICLR | Sell | ICON PLC | $5,170,758 | -71.2% | 20,998 | -70.7% | 0.44% | -70.8% |
| IFRX | Sell | INFLARX NV | $5,177,881 | -39.4% | 1,737,544 | -9.3% | 0.44% | -38.7% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $4,782,957 | +51.0% | 286,748 | +150.1% | 0.40% | +52.8% |
| A | Buy | AGILENT TECHNOLOGIES INC | $4,676,872 | +36.4% | 41,825 | +47.0% | 0.40% | +38.0% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $4,665,340 | -9.3% | 122,643 | +117.3% | 0.40% | -8.1% |
| IQV | Buy | IQVIA HLDGS INC | $4,533,317 | +7.6% | 23,041 | +22.9% | 0.38% | +9.1% |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $4,523,230 | – | 452,323 | +100.0% | 0.38% | – |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $4,421,422 | -24.5% | 1,681,149 | +1.4% | 0.37% | -23.5% |
| AMN | Sell | AMN HEALTHCARE SVCS INCput | $4,259,000 | -58.9% | 50,000 | -47.4% | 0.36% | -58.5% |
| PNTG | Sell | PENNANT GROUP INC | $4,072,456 | -23.2% | 365,899 | -15.2% | 0.34% | -22.1% |
| MOH | Sell | MOLINA HEALTHCARE INC | $4,011,406 | -37.3% | 12,234 | -42.4% | 0.34% | -36.6% |
| GOSS | Buy | GOSSAMER BIO INC | $3,687,519 | +309.9% | 4,427,857 | +490.6% | 0.31% | +316.0% |
| PKI | Buy | REVVITY INC | $3,619,669 | +43.0% | 32,698 | +53.4% | 0.31% | +44.3% |
| CVAC | Buy | CUREVAC N V | $3,529,703 | -5.2% | 516,794 | +44.6% | 0.30% | -3.9% |
| BIOHAVEN LTD | $3,409,989 | +8.7% | 131,103 | 0.0% | 0.29% | +10.3% | ||
| PODD | New | INSULET CORP | $3,396,978 | – | 21,299 | +100.0% | 0.29% | – |
| MRUS | Buy | MERUS N V | $3,159,956 | -8.5% | 134,010 | +2.1% | 0.27% | -7.6% |
| STRO | Buy | SUTRO BIOPHARMA INC | $2,670,644 | -23.2% | 769,638 | +2.9% | 0.23% | -22.3% |
| RGEN | Sell | REPLIGEN CORP | $2,568,489 | -72.5% | 16,153 | -75.6% | 0.22% | -72.2% |
| ARGX | Buy | ARGENX SEsponsored adr | $2,244,291 | +38.6% | 4,565 | +9.9% | 0.19% | +40.7% |
| MEDP | Sell | MEDPACE HLDGS INC | $2,136,313 | -42.8% | 8,823 | -43.3% | 0.18% | -42.2% |
| AVTR | New | AVANTOR INC | $1,781,155 | – | 84,495 | +100.0% | 0.15% | – |
| BBIO | New | BRIDGEBIO PHARMA INCput | $1,471,446 | – | 55,800 | +100.0% | 0.12% | – |
| XBI | New | SPDR SER TRs&p biotech | $1,460,400 | – | 20,000 | +100.0% | 0.12% | – |
| XOMA | XOMA CORP DEL | $1,267,396 | -25.4% | 89,950 | 0.0% | 0.11% | -24.6% | |
| BDTX | Sell | BLACK DIAMOND THERAPEUTICS I | $967,566 | -55.2% | 337,131 | -21.1% | 0.08% | -54.4% |
| AFMD | AFFIMED N V | $801,287 | -20.1% | 1,676,684 | 0.0% | 0.07% | -19.0% | |
| AVTE | AEROVATE THERAPEUTICS INC | $681,784 | -20.9% | 50,242 | 0.0% | 0.06% | -19.4% | |
| AADI BIOSCIENCE INC | $493,283 | -29.2% | 101,918 | 0.0% | 0.04% | -27.6% | ||
| ACIU | AC IMMUNE SA | $355,079 | -3.6% | 124,589 | 0.0% | 0.03% | -3.2% | |
| FGEN | Exit | FIBROGEN INC | $0 | – | -5,600 | -100.0% | -0.00% | – |
| FGEN | Exit | FIBROGEN INCput | $0 | – | -38,800 | -100.0% | -0.01% | – |
| SBTX | Exit | ARS PHARMACEUTICALS INC | $0 | – | -48,788 | -100.0% | -0.03% | – |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -74,797 | -100.0% | -0.06% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -55,176 | -100.0% | -0.13% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -228,679 | -100.0% | -0.14% | – |
| Exit | GOHEALTH INCcl a new | $0 | – | -104,820 | -100.0% | -0.17% | – | |
| PRTK | Exit | PARATEK PHARMACEUTICALS INC | $0 | – | -1,327,857 | -100.0% | -0.24% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -503,079 | -100.0% | -0.34% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -450,622 | -100.0% | -0.40% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -171,378 | -100.0% | -0.55% | – |
| MODN | Exit | MODEL N INC | $0 | – | -223,168 | -100.0% | -0.66% | – |
| ABCM | Exit | ABCAM PLCads | $0 | – | -499,394 | -100.0% | -1.02% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -356,875 | -100.0% | -1.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.